Folate receptor beta 2 (FOLR2) is one of the prognostic genes associated with the breast cancer tumour microenvironment (36), and patients with high FLOR2 expression in lung adenocarcinoma have longer overall survival (37). This evidence concerns the gene FOLR2 and breast carcinoma.